Related by context. All words. (Click for frequent words.) 71 L BLP# 69 Phase #b/#a 69 Theratope 68 MAXY VII 68 Civacir 68 OvaRex ® MAb 68 Eligard ® 68 alvespimycin 68 celgosivir 67 UVIDEM 67 oral methylnaltrexone 67 DPX Survivac 67 Dalbavancin 67 elotuzumab 67 HuMax CD4 67 YONDELIS 67 Insegia 67 tramiprosate Alzhemed TM 67 FluINsure 67 Protexia ® 67 HepeX B 66 Stimuvax 66 TOCOSOL Paclitaxel 66 rThrombin 66 Uvidem 66 Asentar 66 GRNVAC1 66 trastuzumab DM1 T DM1 66 Viramidine 66 MAXY alpha 66 Phase IIb III 66 AQ4N 66 faropenem 66 Shigamabs ® 66 StaphVAX R 66 ruxolitinib 66 ESTRASORB 66 Surfaxin LS 66 pradefovir 66 dacetuzumab 65 Kosan dependence 65 phase IIb clinical 65 EndoTAG TM -1 65 Oncaspar 65 JAK inhibitor 65 Cetrorelix 65 subcutaneous formulation 65 tolevamer 65 midstage trials 65 ASONEP 65 Shigamabs R 65 Azedra 65 ONCONASE R 65 THALOMID 65 IND submission 65 BLA filing 65 SAR# [004] 65 TELINTRA 65 Phase 2a clinical trials 65 Evoltra ® 65 Arranon 65 ridaforolimus 65 bicifadine 65 Allovectin 7 65 Dacogen injection 65 Plicera 65 IMA# 65 Phase Ib II 65 bardoxolone 64 Cloretazine ® 64 GLP toxicology studies 64 HuLuc# 64 hoFH 64 lumiliximab 64 HuCAL antibodies 64 vosaroxin 64 Phase IIb clinical trials 64 Virulizin R 64 Tyzeka Sebivo 64 tremelimumab 64 zanolimumab 64 Ramoplanin 64 injectable formulations 64 volociximab 64 AERx iDMS 64 IMC #B 64 Tykerb lapatinib 64 AEG# 64 GLP toxicology 64 Japanese Encephalitis vaccine 64 rPA anthrax vaccine 64 oral prodrug 64 UPLYSO 64 danoprevir 64 Onco TCS 64 BLP# Liposome Vaccine 64 TACI Ig 64 Amoxicillin PULSYS Phase III 64 Specifid 64 tanespimycin 64 Staphylococcus aureus Polysaccharide Conjugate 64 valopicitabine 64 methylnaltrexone 64 eniluracil 64 Phase III Pivotal 64 PANVAC VF 64 Onalta 64 PRT# 64 SEPET TM 64 Zemiva TM 64 LEP ETU 64 ARIKACE ™ 64 preclinical toxicology 64 RAPTIVA R 64 Octreotide 64 FLUVIRIN vaccine 64 Phase lll 64 pafuramidine 64 Mycograb 64 forodesine 64 PSMA ADC 64 G#DT 64 PDE4 inhibitor 64 ularitide 64 Velcade bortezomib 64 phase IIb trial 64 Pimavanserin 63 telaprevir VX 63 Urocidin TM 63 KNS # 63 GVAX ® 63 CCR5 mAb 63 PREOS R 63 Androxal TM 63 ocrelizumab 63 INCB# [001] 63 EndoTAG TM 63 ZADAXIN ® 63 Xcytrin R 63 Allovectin 7 r 63 nalbuphine ER 63 MAA submission 63 ONTAK 63 investigational hepatitis B 63 rindopepimut 63 HIV integrase inhibitor 63 registrational 63 ATryn ® 63 Panzem R NCD 63 laninamivir 63 Factor VIIa 63 dirucotide 63 R#/MEM 63 Cloretazine R 63 Nexavar sorafenib 63 atacicept 63 HuMax TAC 63 Nanobody R 63 zileuton CR 63 Canvaxin 63 lapatinib Tykerb 63 tramiprosate ALZHEMED TM 63 HGS# 63 fund BioSante LibiGel 63 Topical Interferon Alpha 2b 63 Immunotherapeutic 63 PDE# inhibitors 63 MK #B 63 Prosaptide 63 MOZOBIL 63 Davanat 63 StaphVax 63 rhMBL 63 Phenoptin 63 Protexia R 63 Aganocide 63 Icatibant 63 confirmatory Phase III 63 deforolimus 63 IV APAP 63 inhaled AAT 63 OvaRex R 63 cathepsin K inhibitor 63 Prodarsan 63 subcutaneous RELISTOR 63 MAGE A3 ASCI 63 Solazed 63 TBC# 63 INTEGRILIN 63 CDP# 63 RIGScan CR 63 SNT MC# 63 phase IIb III 63 miconazole MBT 63 ALN PCS 63 Phase IIIb clinical 63 blinatumomab 63 Saforis 63 Bicifadine 63 midstage clinical 63 LEVADEX ™ 63 ISTODAX 63 Aurograb 63 Alzhemed TM 63 Syncria 63 Amigal 63 PhosLo 63 talactoferrin 63 EOquin 63 AERx ® 63 Altastaph 63 HGS ETR2 63 IND enabling 63 Phase Ib study 63 outlicensing 63 Erbitux cetuximab 63 Prednisporin TM 62 Phase Ib clinical 62 Panitumumab 62 CCX# 62 Plenaxis R 62 CONBRIZA 62 rhThrombin 62 candidate CRLX# 62 HCD# [002] 62 GED aPC 62 TELCYTA 62 HEPLISAV TM 62 BIM #A# 62 including eniluracil ADH 62 velafermin 62 Somatuline R Depot 62 Actimmune ® 62 AVAX 62 pivotal bioequivalence 62 RhuDex ® 62 Tavocept 62 Rotarix R 62 HGS ETR1 62 Proellex TM 62 PLK1 SNALP 62 SYCREST 62 Voraxaze 62 histamine dihydrochloride 62 INTERCEPT platelets 62 teduglutide 62 Zerenex 62 EGRIFTA TM 62 PSN# [002] 62 Hedgehog antagonist 62 Prodarsan R 62 nonclinical studies 62 docetaxel Taxotere R 62 CRMD# 62 APTIMA HPV assay 62 Corlux 62 Omigard 62 cMET 62 recombinant biopharmaceutical 62 torezolid phosphate 62 recombinant factor VIIa 62 bioequivalency 62 Dextofisopam 62 RECOTHROM R 62 Pafuramidine 62 Amrubicin 62 Panzem 62 BrachySil TM 62 WILEX 62 BAY #-# 62 HepaGam B 62 riociguat 62 Desmoteplase 62 apaziquone 62 cinacalcet HCl 62 MVA BN R 62 HspE7 62 RELISTOR ® 62 Trizytek 62 vidofludimus 62 tafamidis 62 Troxatyl 62 LentiVector technology 62 Fortovase 62 OvaRex 62 midstage studies 62 Stedivaze 62 PLAVIX ® 62 TYZEKA 62 Oasmia 62 CEQ# 62 Junovan 62 Archexin 62 sitaxsentan 62 Fx #A 62 ATL# [002] 62 Increlex TM 62 Lupuzor 62 AdhTAP 62 Prodarsan ® 62 SparVax TM 62 mertansine 62 clevudine 62 Fibrillex TM 62 vismodegib 62 CCR5 inhibitor 62 Vaxfectin TM 62 Bioral Amphotericin B 62 TRISENOX 62 enzastaurin 62 novel therapeutic antibodies 62 Fodosine 62 XL# XL# XL# XL# 62 eliglustat tartrate 62 EP #R 62 Biologic License Application BLA 62 cMET inhibitor 62 Phase #/#a 62 Annamycin 62 Phase III TRIST 62 RELOVAIR ™ 62 PREGNANT Study 62 TLK# 62 ATG Fresenius S 62 Rasagiline 62 ZOLINZA 62 oxaliplatin Eloxatin 62 successfully commercialize Iluvien 62 DXL# 61 oral PTH 61 dalbavancin 61 Proquin XR 61 MOVIPREP R 61 therapeutic peptide 61 R#/MEM # 61 Reverset 61 CINTREDEKIN BESUDOTOX 61 oral salmon calcitonin 61 iii GTx 61 Aurexis 61 Mepact 61 IXIARO 61 metaglidasen 61 ChimeriVax JE 61 teriflunomide 61 apricitabine 61 Rotarix ® 61 LymphoStat B Phase 61 SILENOR 61 NEUGENE R 61 Sulonex TM 61 Cintredekin Besudotox 61 cystinosis patients 61 taribavirin 61 PEG SN# 61 Adentri 61 PRECISE trial 61 iclaprim 61 oral taxane 61 cannabinor 61 Rhucin R 61 Valortim TM 61 HCV polymerase 61 daptomycin 61 Tocosol Paclitaxel 61 Spiegelmer ® 61 OHR/AVR# 61 Voraxaze ™ 61 oxymorphone ER 61 Sular formulation 61 PEARL SC 61 epothilone 61 LymphoStat B TM 61 MyVax ® 61 phase IIa clinical 61 GVAX R 61 Firdapse 61 HQK 61 ITAX 61 Itopride 61 ApoB SNALP 61 non nucleoside HCV 61 docetaxel Taxotere ® 61 Veronate 61 ELACYT 61 MNTX 61 ZK EPO 61 Maxy G# 61 rolapitant 61 TRO# 61 telomerase therapeutic 61 personalized immunotherapy 61 Zenvia ™ 61 Vectibix panitumumab 61 IL# PE#QQR 61 Zometa zoledronic acid 61 incyclinide 61 SPRYCEL ® 61 HCV protease inhibitor 61 Hedgehog Pathway Inhibitor 61 multicenter Phase II 61 immunotherapeutic vaccine 61 oncolytic virus therapies 61 VaxImmune 61 FOLOTYN ® 61 ZEGERID Capsules 61 casopitant 61 Egrifta 61 BioGeneriX 61 therapeutic monoclonal antibody 61 Gammagard Liquid 61 Orencia abatacept 61 SinuNase ™ 61 motesanib 61 Potelligent Technology 61 acyclovir Lauriad R 61 clevidipine 61 lucinactant 61 glucokinase activator 61 BLA submission 61 isavuconazole 61 ANTEGREN 61 Cloretazine 61 Proxinium TM 61 ganaxolone 61 LE SN# 61 INS# [001] 61 #D#C# 61 H#N# VLP vaccine 61 GSK# [002] 61 BioNumerik 61 BCR ABL inhibitor 61 apoptosis inducer 61 HCV protease inhibitors 61 Telintra 61 Omigard TM 61 motexafin gadolinium Injection 61 clinical pharmacology studies 61 Nanobody ® 61 BRIM3 61 Soliris TM eculizumab 61 MAXY G# 61 Tekturna Rasilez 61 trastuzumab DM1 61 SparVax 61 methylnaltrexone bromide 61 ALN RSV# 61 APTIVUS 61 StaphVAX 61 ROTATEQ 61 eprotirome 61 Vicriviroc 61 PrevOnco 61 ABILIFY ® 61 Exelbine 61 siRNA therapeutics 61 Dasatinib 61 Technosphere Insulin 61 ChronVac C 61 initiated Phase Ib 61 TroVax ® 61 lomitapide 61 cGMP manufacture 61 MyVax R 61 IV Busulfex 61 Diamyd ® 61 hepatitis C HCV 61 Hematide ™ 61 interferon gamma 1b 61 Nycomed GmbH 61 Zadaxin 61 phase IIb 61 Neo Kidney Augment ™ 61 Trofex 61 apricitabine ATC 60 synthetic retinoid 60 Azilect ® 60 Somatuline R Autogel R 60 supplemental biologics 60 CLIRS trial 60 cancer immunotherapies 60 Cinryze ™ 60 cilengitide 60 EVIZON TM squalamine lactate 60 Aerosurf 60 Triapine R 60 NASDAQ PGNX 60 Marqibo TM 60 JAK3 inhibitor 60 oral deforolimus 60 adecatumumab MT# 60 RITUXAN 60 PF # [002] 60 MBP# [001] 60 VALOR trial 60 BEXXAR 60 HDL Selective Delipidation 60 Ventavis ® 60 tiapamil 60 Campath ® 60 Fibrillex 60 epigenetic therapies 60 MGd 60 Nuvion 60 Ethyol 60 squalamine 60 Imvamune 60 XL# XL# 60 trivalent influenza vaccine 60 Nanobody 60 intravenous AAT 60 EHT AGN 60 Allovectin 7 R 60 CCR5 inhibitors 60 Mipomersen 60 Marketing Authorisation Application MAA 60 phase IIa 60 opioid bowel dysfunction 60 Prestara 60 adecatumumab 60 PROSTVAC TM 60 Onconase 60 Starlix 60 Phase #b/#a clinical 60 NXL# 60 Vitaxin 60 oral ridaforolimus 60 Aurora kinase inhibitor 60 Oglemilast 60 CBLC# 60 Azedra TM 60 IMVAMUNE TM 60 Cancidas 60 XOMA 3AB 60 CMV vaccine 60 fipamezole 60 Fentanyl TAIFUN R 60 HGS ETR1 mapatumumab 60 OVATURE 60 fostamatinib 60 Serdolect ® 60 Litx 60 dose escalation Phase 60 POSIDUR TM 60 CytoFabTM 60 StemEx R 60 Rescula 60 Ceflatonin 60 severe hypercholesterolemia 60 Shire BioChem Inc. 60 Cinquil 60 Phase #b/#a trial 60 CAELYX 60 micafungin 60 refractory gout 60 rALLy 60 Oncoscience AG 60 DOS# 60 Poly ICLC 60 Heplisav 60 LE DT 60 Phase IIB 60 Thiovir 60 novel trazodone formulation 60 Removab 60 Asentar TM 60 dexanabinol 60 NEBIDO 60 Ecallantide 60 Maribavir 60 rFactor XIII 60 nucleotide analog 60 Bonefos 60 thymalfasin 60 PREOS 60 tezampanel NGX# 60 dirucotide MBP# 60 VEGF Trap 60 LB# [003] 60 OPAXIO 60 mapatumumab 60 brivaracetam 60 Neulasta ® 60 ATryn R 60 Solazed TM 60 Genz # 60 otelixizumab 60 Personalized Immunotherapy 60 Liprostin 60 Lovaxin C 60 alvimopan 60 Phase IIIb study 60 ganetespib 60 RSD# oral 60 EOquin TM 60 initiate Phase 1b 60 selective S#P# receptor agonist 60 Aviptadil 60 Tolevamer 60 Vernakalant 60 ALN TTR# 60 Thalomid ® 60 BeneFIX 60 Symadex 60 TransVax ™ 60 SNALP technology 60 Sym# 60 #I TM# 60 GnRH antagonists 60 OncoVEX 60 Cloretazine R VNP#M 60 PXD# 60 Alvesco R 60 LibiGel ® testosterone gel 60 ketolide antibiotic 60 leading oral taxane 60 Ereska 60 thalidomide Thalomid 60 Ruconest 60 IMVAMUNE R 60 virus HCV protease inhibitor 60 registrational trials 60 TMC# [002] 60 Pivotal Phase III 60 investigational therapies 60 RGB # 60 SparVax ™ 60 phase Ib clinical 60 CCR9 antagonist 60 Exherin TM 60 AE# vaccine 60 Aganocide ® 60 Estrasorb 60 investigational humanized monoclonal antibody 60 sodium thiosulfate STS 60 Azedra ™ 60 LAF# 60 Bifeprunox 60 IV acetaminophen 60 CORLUX CORT # 60 ixabepilone 60 Adenuric R 60 Nascobal 60 Ceflatonin R 60 AP# [003] 60 miconazole Lauriad ® 60 blood clot dissolver 60 Plenaxis TM 60 Angiox ® 60 Zenapax 60 dose escalation clinical 60 Zavesca r 60 omecamtiv mecarbil 60 Levetiracetam 60 OLEPTRO TM 60 Tracleer R 60 biologic therapeutics 60 generation purine nucleoside 60 TOCOSOL Camptothecin 60 MIST II 60 TLR9 agonist 60 Hiberix 60 SEBIVO 60 Firazyr ® 60 Presents Preclinical 60 Thelin tm 60 Sebivo 60 Fludara ® 60 Belinostat 60 novel VDA molecule 60 darapladib 60 adipiplon 60 fusion enhancers 60 XIAPEX 60 KRYSTEXXA TM pegloticase 60 systemic RNAi 60 PEP# [003] 60 Targretin 60 PI3K/Akt pathway inhibitor 60 intranasal formulation 60 custirsen 60 REBETOL combination therapy 59 EndoTAG 59 ADVEXIN clinical 59 CIP TRAMADOL ER 59 Phase IIA 59 NSABP C 59 Exelixis compounds 59 DU #b 59 TRAIL receptor antibodies 59 Bendamustine 59 Phase III Clinical Trial 59 sapacitabine 59 aflibercept 59 antibody MAb 59 Lixivaptan 59 BRILINTA 59 Velac 59 liprotamase 59 Bezielle 59 Phase III clinical 59 Initiates Phase III 59 Xanafide 59 albiglutide 59 evaluating tivozanib 59 eprodisate KIACTA TM 59 CELVAPAN H#N# 59 Phase 2a trial 59 maribavir 59 NEUMUNE 59 urocortin 2 59 Numax 59 faropenem medoxomil 59 alemtuzumab Campath 59 reslizumab 59 TP# CETi 1 59 Reports Preclinical Data 59 elvucitabine 59 CCR5 receptor antagonist 59 rilpivirine 59 TKM Ebola 59 balsalazide tablet 59 Zalypsis 59 Gattex 59 ORENCIA R 59 amrubicin 59 tamibarotene 59 DEB# 59 ELND# 59 tasimelteon 59 GPR# agonist 59 MethyPatch 59 forodesine hydrochloride 59 Arixtra 59 OLEPTRO 59 AeroLEF TM 59 IoGen 59 PROSTVAC ® 59 AnGes 59 REOLYSIN ® 59 antibiotic telavancin 59 PrevOnco ™ 59 Rhucin ® 59 antiplatelet agent 59 BIOCEUTICALS 59 CERVARIX 59 Selective Electrochemical Tumor Ablation 59 Pruvel 59 Neuradiab 59 sargramostim 59 Cand5 59 CytoGam 59 AZILECT ® 59 Myocet 59 tesmilifene 59 Luveris 59 Progenta TM 59 oral calcitonin 59 Zerenex ™ 59 PROSTASCINT R 59 TRX1 59 Hepatocellular Carcinoma HCC 59 Aryplase 59 XP# XP# 59 Glybera 59 Vidofludimus 59 LGLS 59 ACEON R 59 Elocalcitol 59 Cleviprex TM clevidipine 59 SCIB1 59 GSK# [001] 59 REMINYL ® 59 PEG Interferon lambda 59 KRN# 59 Initiates Clinical 59 Loramyc R 59 iniparib 59 Phase 1a clinical 59 Zensana 59 PRIMO CABG 59 Preotact 59 XmAb# 59 CA9 SCAN 59 antineoplastic 59 SUTENT ® 59 LidoPAIN SP 59 IAP inhibitors 59 investigational protease inhibitor 59 Ampligen r 59 KIACTA ™ 59 Intraject 59 postapproval 59 GRN# 59 Fluviral 59 Gentamicin Surgical Implant 59 fosbretabulin 59 LHRH antagonist 59 Japanese Encephalitis Vaccine 59 Kissei Pharmaceutical 59 punctal plug 59 TOLAMBA 59 OXi# 59 Initiates Phase II 59 baminercept 59 Vimpat ® lacosamide 59 Tech DVAX 59 RhuDex TM 59 Solasia 59 neratinib 59 Shigamabs 59 im peramivir 59 SUCCEED trial 59 Virulizin ® 59 Tibotec BVBA 59 Preclinical studies suggest 59 Virulizin 59 MEK inhibitor 59 Rhein Biotech GmbH 59 Neo Kidney Augment 59 ORENCIA ® 59 factor VIIa 59 Nektar pulmonary 59 Tamibarotene 59 Zolinza 59 TAFA# 59 torsemide ER 59 Ceplene TM 59 Evoltra 59 delivery polymer matrix 59 oral antiviral 59 ELIQUIS 59 Orathecin 59 FavId 59 rhFVIIa 59 PCA3 assay 59 ONCASPAR 59 NovaBay Aganocide compounds 59 hepatitis B vaccine Heplisav 59 CytoFab 59 L DOS# 59 Urokinase 59 Quinvaxem TM 59 PEG INTRON 59 radiation sensitizer 59 CD# monoclonal antibody 59 CR# vcMMAE 59 Dacogen TM 59 regorafenib 59 AQUAVAN R 59 JP-#/fipamezole 59 PRESEPT study 59 PD LID 59 Diosynth 59 cytokine refractory 59 GATTEX ® 59 Poly ICR 59 PROVIGIL 59 hormone LHRH antagonist 59 nitric oxide donating prostaglandin 59 RTP #i 59 KAPVAY ™ 59 unoprostone isopropyl 59 BRIM2 59 Rhucin 59 intranasal delivery 59 Alfimeprase 59 Glassia 59 aplindore 59 Huntexil 59 candidate AQ4N 59 adrenergic regulation 59 registrational trial 59 TheraCIM 59 Cytolin 59 Chimigen TM 59 thorough QT 59 Clolar ® 59 r hGH 59 MyVax 59 RiVax 59 DCVax R Prostate 59 Kineret ® 59 Cerashield 59 daclizumab 59 Cautreels 59 Ascend Therapeutics 59 Enhanze 59 Unit Dose Budesonide 59 Entereg TM 59 EVIZON TM 59 Hectorol R 59 adjuvant colon cancer 59 Trovax 59 GlaxoSmithKline Biologicals SA 59 ENRICH trial 59 budesonide foam 59 PentaStaph 59 hypoxia activated prodrug 59 MGN# 59 AGGRASTAT ® 59 FluBlok 59 liposomal formulation 59 GATTEX ™ 59 Urocidin 59 SERMs 59 ICA # 59 RiVax ™ 59 prostone 59 OMP #M# 59 calcitonin 59 anticancer therapy 59 BEMA TM Fentanyl 59 Loramyc 59 HepaGam B R 59 IGF 1R inhibitor 59 GlaxoSmithKline Tykerb 59 Soliris eculizumab 59 RSD# 59 Targretin capsules 59 levocetirizine 59 DYNEPO 59 Tesmilifene 59 phase III isavuconazole 59 canakinumab 59 TAXOL 59 Panzem R 59 Rebif ® 59 OncoVex 59 Temsirolimus 59 MGCD# [001] 59 confirmatory clinical 59 THR beta agonist 59 IND CTA 59 multidose 59 hepatitis B immune globulin 59 cediranib 59 HCV nucleoside 59 diarrhea predominant irritable 59 GLASSIA ™ 59 miRNA therapeutics 59 ATL# [001] 59 PGL# 59 luliconazole 59 GTC recombinant human 59 Trofex TM 59 LibiGel ® 59 goserelin 59 Solulin 59 MVA BN 59 Phase IIa trials 59 zileuton IV 59 CholeraGarde R 59 telomerase inhibitor drug 59 Raptiva R 59 Cellegesic 59 Ixiaro 59 Inc. www.micromet inc.com 59 NerPharMa 59 piperacillin tazobactam 59 Phase III registrational 59 BioVant 59 GATTEX TM 59 GALNS 59 Kamada AAT 59 aerosolized AAT 59 intravenous formulations 59 masitinib 59 huC# DM4 59 BENLYSTA ® 59 Silodosin 59 oral mTOR inhibitor 59 TKM ApoB 59 MKC# MT 59 GV# [001] 59 XL# anticancer compounds 58 novel emulsion formulation 58 inhibitor RG# 58 fidaxomicin Phase 3 58 Revlimid lenalidomide 58 Phase III confirmatory 58 Interferon beta 1b 58 rxRNA 58 Generx TM 58 antisense inhibitors 58 solanezumab 58 kidney urologic 58 URG# 58 NeuVax 58 PEGPH# 58 Hedgehog agonist 58 DSMB recommended 58 SIRT1 activators 58 panitumumab Vectibix 58 BiTE antibody 58 brentuximab vedotin SGN 58 NV1FGF 58 TRISENOX ® 58 Campto